Eko Devices

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Eko Devices sits in the top decile of US sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count).

16 total trials 5 currently recruiting 8 completed top decile by trial count

Eko Devices: 16 sponsored US clinical trials, 5 recruiting.

Eko Devices sponsors 16 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 8 completed. The most-studied condition in this pipeline is Lung Diseases, with 2 trials.

Top-decile sponsor footprint

Eko Devices ranks in the top decile of sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 39/100

8 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

16 total, page 1 of 1

RECRUITING

Data Collection Using Eko Digital Devices in a Clinical Setting

NCT07227376

RECRUITING

Improvement of an Algorithm to Detect Structural Heart Murmurs in Adult Patients Using Electronic Stethoscopes

NCT07202104

RECRUITING

Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope

NCT07136623

RECRUITING

Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG

NCT07087613

RECRUITING

Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope

NCT05873387

ACTIVE NOT RECRUITING

Data Collection For Adventitious Lung Sounds Algorithm Using Eko Digital Devices in a Clinical Setting

NCT07360522

COMPLETED

Dialysis Access Monitoring Using a Digital Stethoscope-Based Deep Learning System

NCT05105503

COMPLETED

Real-World Evaluation of Eko Algorithms in a Point of Care Setting

NCT05459545

TERMINATED

Real-World Evaluation of Eko Murmur Analysis Software in a Point of Care Setting

NCT05176899

COMPLETED

Low Ejection Fraction in Single Lead ECG- Ochsner

NCT05010642

COMPLETED

Detection of Heart Conditions Using Artificial Intelligence

NCT04933890

COMPLETED

Low Ejection Fraction in Single Lead ECG

NCT05010655

COMPLETED

Heart Failure Monitoring With Eko Electronic Stethoscopes (CardioMEMS)

NCT05080504

COMPLETED

Detection of Heart Conditions With Single Lead ECG Using Artificial Intelligence

NCT04400435

TERMINATED

Heart Failure Monitoring With Eko Electronic Stethoscopes

NCT04404452

COMPLETED

Development of an Algorithm to Differentiate Heart Murmurs Using Electronic Stethoscopes

NCT04400513

What is open in the Eko Devices pipeline

5 recruiting of 16 indexed (31% open); 8 completed (50%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Lung Diseases (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Eko Devices: open-pipeline peers nationwide

Peers matched on 16 registered trials and 31% open enrollment, not the therapeutic-area sidebar.

Eko Devices sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1020304050 0%10%20%30%40% Total trials Recruiting share Eko DevicesAccelerated Community Oncology Research NetworkAltimmuneAmerican UniversityAnthera PharmaceuticalsVarian, a Siemens Healthineers CompanyWright State UniversityLaureate Institute for Brain ResearchPhilips Clinical & Medical Affairs Global
Eko Devices sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Eko Devices sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 16 trials (± recruiting share)

Sponsors near 31% open enrollment (± trial volume)

What to do with this Eko Devices page

16 registered trials is a research-attention snapshot, not an endorsement of Eko Devices or any single study.

  • 5 of Eko Devices's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Lung Diseases is the condition Eko Devices studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Lung Diseases trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Eko Devices pipeline card: 16 registered trials from official public datasets.Report a data error.